Prof. Ramesh K. Goyal
Drug discovery (Preclinical and clinical regulatory efficacy, safety and toxicological studies) related to diabetes, its associated cardiovascular complications; cancer and inflammatory disorders like psoriasis and multiple sclerosis.
Prof. Shyam S. Agrawal
Drug discovery, drug development and conducting clinical trials in the area of antifertility, oncology, cosmotovigilance and herbovigilance. Study of oral contraceptive and antiovulatory agents in rats. Screening for estrogenic and antiestrogenic activities of herbs and herbal formulation from Dabur Research Foundation.
Prof. Suresh K. Gupta
Management of cataract, glaucoma and diabetic retinopathy. Management of various cardiovascular diseases by natural products. Role of Pharmacoeconomic and outcomes research for the better management of health care system in the Country.
Prof. Raman Dang
In Vitro Cultures and Developing of Protocols for Standardization of Herbals Phytochemistry.
Prof. Dharm Pal Pathak
Drug design, synthesis and pharmacological evaluation of fatty acid derivatives, oxadiazole and benzoxazole derivatives. Chemical, biological, radiological and nuclear decontamination and mitigation in case of emergencies.
Prof. Prabhat K. Sahoo
Nanoparticle drug delivery, Particulate drug delivery, Topical drug delivery & Ocular drug delivery. Method development and validation for bulk drug and formulations.
Prof. Sharad R. Wakode
Designing, planning and synthesizing new organic molecules of therapeutic interest and its screening. Isolation, identification, characterisation of phyto constituents from herbal drugs for their anti-inflammatory, analgesic, antimicrobial activity.
Prof. Harvinder Popli
Application of Nanotechnology for development of differentiated drug Delivery Systems for topical and Parental Release, Regulatory policies for Medical Devices, IVD and Biological
Dr. Sushma Talegaonkar
Novel drug delivery systems and Development of Nanoformulations for bioavailability enhancement and Drug targeting & Safety, Women Health and Physical Therapy
Dr. Mukesh Nandave
Investigating the role of use of nutraceuticals, herbomineral formulations, plant extracts & constituents for Myocardial ischemia & reperfusion injury, Diabetes, Obesity, Pain management. Other areas of Dr. Nandave includes effects of Sirtuin1 (Sirt1) activation in ageing-related cardiovascular diseases, System Xc- antiporter inhibition in epileptogenesis, and Targeting AMPK, SIRT1, and cholesterol pathways for prevention of metabolic abnormalities-associated cancer.
Dr. Jaseela Majeed
Drug design and synthesis of lead molecules of therapeutic interest and biological evaluation of these molecules for in vitro and in vivo anticancer screening. Analytical method development of drugs and formulations and stability studies including accelerated stability testing of finished products
Dr. Meenakshi Chauhan
Vesicular/particulate Drug delivery- For improved bio-pharmaceutical performance through topical and oral routes. Ophthalmic drug Delivery systems- Formulation approaches to improve ocular bioavailability of drugs.Protein/peptide drug delivery Technology.
Mr. Bhag Chand
Pharmaceutical Dosages forms and Drug Delivery System.
Mr. Anil Kumar Sharma
Nutraceutical and functional foods, novel drug delivery systems (NDDS), drug delivery, nanotechnology, health science/life science, and biology/cancer biology/neurobiology.
Mr. Satish Manchanda
Nano-drug delivery, ethosomal drug delivery, particulate drug delivery,topical drug delivery, ocular drug delivery, transdermal drug delivery, HPLC method development & validation.
Dr. Geeta Aggarwal
Transdermal and Topical drug delivery for antipsychotics, fungal infections, psoriasis using colloidal carriers, drug targeting particularly to colon and lungs by smart nano-formulations and nano-materials, exploitation of natural polymers and potential lipids for enhancement of bioavailability of poorly soluble drugs
Dr. Madhu Gupta
Pharmaceutical nanotechnology and targeted drug delivery related to cancer, fungal infection, and psoriasis, as well as linked to nanoformulations for magical molecule delivery, bioligands for targeting of bioactives and drug moiety, biopolymers, cancer nanomedicine as well as topical delivery.
Dr. Rajani Mathur
Metabolic disorders and its complications. Pharmacological screening of potential drugs for Cardioprotective effects, Ocular therapeutics. Molecular mechanisms of metabolic disorders.
Mrs. S. Latha
Pharmacological Screening of Anti-angiogenic herbal drugs and their isolated compound. Neuroprotective effect of herbal extract and isolated compound.
Mr. Sachin Kumar
Research is focused on the evaluation of antioxidant activity and cytotoxicity of Indian medicinal plants and quantification of active constituents with HPLC and GC-MS.
Dr. Ajit Kumar Thakur
Research focused in Neuropharmacology & Psychopharmacology with specific reference to investigation of neurotransmitters and biomarkers in CNS comorbidity associated with metabolic disorders & stress
Mrs. Manju Vyas
Standardization and Screening of various activities of Plant extracts.
Mr. Pratap N. Raju
Standardization of phytochemicals and their biological studies.
Mrs. Sakshi Bajaj
Studies and researches into medicinal constituents of plant, involve qualitative and quantitative analysis. Also our desired active metabolites to be isolated and studied as interested lead compound.
Dr. Mahaveer Dhobi
Bioactivity guided isolation and structure elucidation of pure compounds from medicinal plants; Method Development, Validation Standardization and quality control for estimation of analytical markers in plants; Screening of plant extracts and their isolates for Central Nervous System related disorders.
Dr. J. Saminathan
Analytical Method Development and Validation for Newer Drugs for regulatory purpose, appli agion of Quality by Design for fotmulation development specifically for Hepatoprotective, Anti-ulcer, Analgesics and anti-inflammatory drugs.
Mrs. Amrita Parle
Planning, designing, synthesizing, characterizing and screening of new antimicrobial analytical methods like reverse HPLC, HPTLC, UV for DPP4 inhibitors, SGLT2 inhibitors alone and in combination with other antidiabetic drugs.
Dr. Ramesh Bodla
Bio-production of secondary metabolites, synthetic medicinal chemistry for potential drug molecules or drug analogs and their biological screening. Photochemical investigations and screening for biological activity.HPLC method development and validation for drug molecules and their combinations.
Dr. Rajiv Kumar
Designing, synthesizing, characterization of new drug derivatives (incorporating heterocyclic moiety) of therapeutic interest and their screening as antimicrobial, anticonvulsant, analgesic and anti-inflammatory agents (COX-1, COX-2 and ITK inhibitors). Development and validation of analytical methods for drugs and drug formulations.
Drug designing, QSAR study and synthesis of novel heterocyclic compounds and its antimalarial and antimicrobial activity. Characterisation of compounds through IR, NMR and Mass spectra.